114 related articles for article (PubMed ID: 22358671)
1. Cell-matrix interactions in cultured dermal fibroblasts from patients with an inherited connective-tissue disorder.
Baccarani Contri M; Tiozzo R; Croce MA; Andreoli T; De Paepe A
Cytotechnology; 1993 Jan; 11(Suppl 1):S112-4. PubMed ID: 22358671
[TBL] [Abstract][Full Text] [Related]
2. Cell-matrix interactions in cultured dermal fibroblasts from patients with an inherited connective-tissue disorder.
Baccarani Contri M; Tiozzo R; Croce MA; Andreoli T; De Paepe A
Cytotechnology; 1993; 11 Suppl 1():S112-4. PubMed ID: 7763736
[TBL] [Abstract][Full Text] [Related]
3. Abnormal phenotype of in vitro dermal fibroblasts from patients with Pseudoxanthoma elasticum (PXE).
Quaglino D; Boraldi F; Barbieri D; Croce A; Tiozzo R; Pasquali Ronchetti I
Biochim Biophys Acta; 2000 Apr; 1501(1):51-62. PubMed ID: 10727849
[TBL] [Abstract][Full Text] [Related]
4. Characterization of dermal myofibroblast differentiation in pseudoxanthoma elasticum.
Faust I; Donhauser E; Fischer B; Ibold B; Kuhn J; Knabbe C; Hendig D
Exp Cell Res; 2017 Nov; 360(2):153-162. PubMed ID: 28882457
[TBL] [Abstract][Full Text] [Related]
5. Fibroblasts from patients affected by Pseudoxanthoma elasticum exhibit an altered PPi metabolism and are more responsive to pro-calcifying stimuli.
Boraldi F; Annovi G; Bartolomeo A; Quaglino D
J Dermatol Sci; 2014 Apr; 74(1):72-80. PubMed ID: 24461675
[TBL] [Abstract][Full Text] [Related]
6. Immunochemical identification of abnormal constituents in the dermis of pseudoxanthoma elasticum patients.
Baccarani-Contri M; Vincenzi D; Cicchetti F; Mori G; Pasquali-Ronchetti I
Eur J Histochem; 1994; 38(2):111-23. PubMed ID: 7524808
[TBL] [Abstract][Full Text] [Related]
7. Fibrillin immunofluorescence in pseudoxanthoma elasticum.
Godfrey M; Cisler J; Geerts ML; Christiano A; Uitto J; De Bie S; DePaepe A
J Am Acad Dermatol; 1995 Apr; 32(4):589-94. PubMed ID: 7896947
[TBL] [Abstract][Full Text] [Related]
8. Pyrophosphates as a major inhibitor of matrix calcification in Pseudoxanthoma elasticum.
Dabisch-Ruthe M; Kuzaj P; Götting C; Knabbe C; Hendig D
J Dermatol Sci; 2014 Aug; 75(2):109-20. PubMed ID: 24907773
[TBL] [Abstract][Full Text] [Related]
9. Dermal fibroblasts from pseudoxanthoma elasticum patients have raised MMP-2 degradative potential.
Quaglino D; Sartor L; Garbisa S; Boraldi F; Croce A; Passi A; De Luca G; Tiozzo R; Pasquali-Ronchetti I
Biochim Biophys Acta; 2005 Jun; 1741(1-2):42-7. PubMed ID: 15955448
[TBL] [Abstract][Full Text] [Related]
10. Pseudoxanthoma elasticum (PXE): ultrastructural and biochemical study on proteoglycan and proteoglycan-associated material produced by skin fibroblasts in vitro.
Tiozzo Costa R; Baccarani Contri M; Cingi MR; Pasquali Ronchetti I; Salvini R; Rindi S; De Luca G
Coll Relat Res; 1988 Jan; 8(1):49-64. PubMed ID: 3345648
[TBL] [Abstract][Full Text] [Related]
11. Abnormalities of connective tissue components in lesional and non-lesional tissue of patients with pseudoxanthoma elasticum.
Lebwohl M; Schwartz E; Lemlich G; Lovelace O; Shaikh-Bahai F; Fleischmajer R
Arch Dermatol Res; 1993; 285(3):121-6. PubMed ID: 8503691
[TBL] [Abstract][Full Text] [Related]
12. Extracutaneous ultrastructural alterations in pseudoxanthoma elasticum.
Gheduzzi D; Sammarco R; Quaglino D; Bercovitch L; Terry S; Taylor W; Ronchetti IP
Ultrastruct Pathol; 2003; 27(6):375-84. PubMed ID: 14660276
[TBL] [Abstract][Full Text] [Related]
13. Relationship Between Mitochondrial Structure and Bioenergetics in
Lofaro FD; Boraldi F; Garcia-Fernandez M; Estrella L; Valdivielso P; Quaglino D
Front Cell Dev Biol; 2020; 8():610266. PubMed ID: 33392199
[No Abstract] [Full Text] [Related]
14. Serum factors from pseudoxanthoma elasticum patients alter elastic fiber formation in vitro.
Le Saux O; Bunda S; VanWart CM; Douet V; Got L; Martin L; Hinek A
J Invest Dermatol; 2006 Jul; 126(7):1497-505. PubMed ID: 16543900
[TBL] [Abstract][Full Text] [Related]
15. Multidrug resistance protein-6 (MRP6) in human dermal fibroblasts. Comparison between cells from normal subjects and from Pseudoxanthoma elasticum patients.
Boraldi F; Quaglino D; Croce MA; Garcia Fernandez MI; Tiozzo R; Gheduzzi D; Bacchelli B; Pasquali Ronchetti I
Matrix Biol; 2003 Nov; 22(6):491-500. PubMed ID: 14667841
[TBL] [Abstract][Full Text] [Related]
16. Matrix gla protein and alkaline phosphatase are differently modulated in human dermal fibroblasts from PXE patients and controls.
Boraldi F; Annovi G; Vermeer C; Schurgers LJ; Trenti T; Tiozzo R; Guerra D; Quaglino D
J Invest Dermatol; 2013 Apr; 133(4):946-54. PubMed ID: 23223140
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast protein profile analysis highlights the role of oxidative stress and vitamin K recycling in the pathogenesis of pseudoxanthoma elasticum.
Boraldi F; Annovi G; Guerra D; Paolinelli Devincenzi C; Garcia-Fernandez MI; Panico F; De Santis G; Tiozzo R; Ronchetti I; Quaglino D
Proteomics Clin Appl; 2009 Sep; 3(9):1084-98. PubMed ID: 21137008
[TBL] [Abstract][Full Text] [Related]
18. Leg ulceration with histological features of pseudoxanthoma elasticum.
Asad U; Shah S; Parekh P
Proc (Bayl Univ Med Cent); 2020 Oct; 34(1):87-88. PubMed ID: 33456154
[TBL] [Abstract][Full Text] [Related]
19. Characterization of pseudoxanthoma elasticum-like lesions in the skin of patients with beta-thalassemia.
Baccarani-Contri M; Bacchelli B; Boraldi F; Quaglino D; Taparelli F; Carnevali E; Francomano MA; Seidenari S; Bettoli V; De Sanctis V; Pasquali-Ronchetti I
J Am Acad Dermatol; 2001 Jan; 44(1):33-9. PubMed ID: 11148474
[TBL] [Abstract][Full Text] [Related]
20. Calcification of elastic fibers in pseudoxanthoma elasticum.
Truter S; Rosenbaum-Fiedler J; Sapadin A; Lebwohl M
Mt Sinai J Med; 1996; 63(3-4):210-5. PubMed ID: 8692167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
